Does SPARSENTAN Cause Decreased appetite? 75 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Decreased appetite have been filed in association with SPARSENTAN (FILSPARI). This represents 2.3% of all adverse event reports for SPARSENTAN.
75
Reports of Decreased appetite with SPARSENTAN
2.3%
of all SPARSENTAN reports
2
Deaths
10
Hospitalizations
How Dangerous Is Decreased appetite From SPARSENTAN?
Of the 75 reports, 2 (2.7%) resulted in death, 10 (13.3%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SPARSENTAN. However, 75 reports have been filed with the FAERS database.
What Other Side Effects Does SPARSENTAN Cause?
Dizziness (521)
Fatigue (448)
Hypotension (377)
Product use in unapproved indication (262)
Nausea (231)
Peripheral swelling (197)
Headache (186)
Pruritus (171)
Blood creatinine increased (145)
Glomerular filtration rate decreased (141)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which SPARSENTAN Alternatives Have Lower Decreased appetite Risk?
SPARSENTAN vs SPESOLIMAB-SBZO
SPARSENTAN vs SPIRAMYCIN
SPARSENTAN vs SPIRIVA
SPARSENTAN vs SPIRONOLACTONE
SPARSENTAN vs SPRYCEL